Sign in
WithdrawnNo phase

Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm

Key facts

Who runs it
Fred Hutchinson Cancer Center
Where
Seattle, United StatesSee the site
Trial code
Status
Withdrawn
Started
1 Sept 2025
Ended
1 Jan 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Best Practice
  • Palliative Care Consultation
  • Survey Administration
  • Tumor Board Review
Record updated
29 June 2025
Why it stopped
Study closed before opening to accrual; Insufficient staff

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Adults (18 years or older)
  • Pancreatic neoplasm pathology
  • Ability to read, write, and speak in English
  • Has decisional capacity
  • Expected to be seen and discussed at PCSC and seeing a surgeon as part of their tumor board evaluation

Who cannot take part

  • Currently is or previously has received palliative care, or are unwilling to forego palliative care for the first 90 days post randomization
  • Evidence of any behavior, condition, or circumstance (including, but not limited to: blindness, deafness, serious behavior or mental health conditions, discontinuing curative treatment, lack of access to technology, etc) that would interfere with their ability to complete study procedures as noted within the chart
  • Metastatic pancreatic neoplasm
  • Currently incarcerated

Where in United States

  • Fred Hutch/University of Washington Cancer ConsortiumSeattle, United States

About the trial

What the trial wants to find out

This clinical trial evaluates a palliative care consultation for improving communication between providers and patients considering surgery for a pancreatic neoplasm. Pancreatic operations have known complications that can affect quality of life. Palliative care has been shown to improve patient reported quality of life and functional outcomes. Receiving a palliative care consultation may improve communication and decision making for patients considering surgery for a pancreatic neoplasm.

The 2 groups in the trial

  • Arm I (Usual care)Existing treatment, for comparison

    Patients receive usual care and undergo evaluation by a tumor board within 14 days of baseline.

    Treatment: Best Practice, Survey Administration, and Tumor Board Review

  • Arm II (Palliative care visit)Treatment being tested

    Patients attend a palliative care visit over 60 minutes to discuss their illness, quality of life, fears and concerns and communication preferences within 7 days of baseline. Patients also undergo evaluation by a tumor board within 14 days of baseline.

    Treatment: Palliative Care Consultation, Survey Administration, and Tumor Board Review

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Preoperative, Specialty Palliative Care for Patients Considering Pancreatic Surgery: Pilot Feasibility and Acceptability Study
Record updated
29 June 2025